Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cellectar Biosciences, Inc.
University of California, San Francisco
National Institutes of Health Clinical Center (CC)
University of California, San Francisco
Washington University School of Medicine
Children's Oncology Group
City of Hope Medical Center
Children's Oncology Group
Children's Oncology Group
Dana-Farber Cancer Institute
Emory University
Eli Lilly and Company
St. Jude Children's Research Hospital
Medical University of Vienna
Clinica Universidad de Navarra, Universidad de Navarra
M.D. Anderson Cancer Center